[1]董文韬,刘三梅,李杰,等.超广角OCTA对视网膜静脉阻塞眼视网膜无灌注区的检出效果分析[J].眼科新进展,2023,43(1):040-43.[doi:10.13389/j.cnki.rao.2023.0008]
　DONG Wentao,LIU Sanmei,LI Jie,et al.Detection performance of ultra-wide field optical coherence tomography angiography on the retinal non-perfusion areas in eyes with retinal vein obstruction[J].Recent Advances in Ophthalmology,2023,43(1):040-43.[doi:10.13389/j.cnki.rao.2023.0008]
点击复制

超广角OCTA对视网膜静脉阻塞眼视网膜无灌注区的检出效果分析/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
43卷
期数:
2023年1期
页码:
040-43
栏目:
应用研究
出版日期:
2023-01-05

文章信息/Info

Title:
Detection performance of ultra-wide field optical coherence tomography angiography on the retinal non-perfusion areas in eyes with retinal vein obstruction
作者:
董文韬; 刘三梅; 李杰; 黎梦宇; 钟捷
610072　四川省成都市，电子科技大学附属医院，四川省人民医院
Author(s):
DONG Wentao; LIU Sanmei; LI Jie; LI Mengyu; ZHONG Jie
Department of Ophthalmology,Sichuan Provincial People’s Hospital,University of Electronic Science and Technology of China,Chengdu 611731,Sichuan Province,China
关键词:
视网膜静脉阻塞; 光学相干断层扫描血管成像; 造影术; 诊断
Keywords:
retinal vein occlusion;  optical coherence tomography angiography;  angiography;  diagnosis
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2023.0008
文献标志码:
A
摘要:
目的　分析超广角光学相干断层扫描血管成像（OCTA）对视网膜静脉阻塞（RVO）眼视网膜无灌注区的检出效果。
方法　选取2021年11月至2022年4月就诊于四川省人民医院眼科的RVO患者48例（48眼）作为研究对象，其中，视网膜中央静脉阻塞（CRVO）19例19眼，视网膜分支静脉阻塞（BRVO）29例29眼。所有患者均行检眼镜、荧光素眼底血管造影（FFA）和超广角OCTA检查。超广角OCTA检查选择24 mm×20 mm扫描模式。以FFA的检查结果为金标淮，计算超广角OCTA对RVO眼视网膜无灌注区的检出率，并应用受试者工作特征曲线（ROC曲线）分析其检测性能。
结果　本研究共28眼（58.3%）被FFA检出视网膜无灌注区，超广角OCTA检出其中27眼，检出率96.4%，遗漏的一只患眼是由于超广角OCTA检测范围受限所致。在余下的20只患眼中，超广角OCTA更灵敏地检出1只患眼黄斑上方存在视网膜无灌注区，而在FFA图像中这个区域被视网膜出血引起的低荧光所掩盖。ROC分析结果显示：超广角OCTA检测RVO眼视网膜无灌注区的灵敏度、特异度分别为83.3%、100.0%，AUC为0.957。
结论　超广角OCTA对RVO眼视网膜无灌注区检出率高、耗时短，准确率高，且能发现被FFA遗漏的无灌注区。
Abstract:
Objective　To analyze the detection rate of retinal non-perfusion areas in eyes with retinal vein obstruction (RVO) by ultra-wide field optical coherence tomography angiography (OCTA).
Methods　A total of 48 RVO patients (48 eyes) visited the Department of Ophthalmology, Sichuan Provincial People’s Hospital from November 2021 to April 2022 were included, comprising 19 patients (19 eyes) with central retinal vein occlusion and 29 patients (29 eyes) with branch retinal vein occlusion. All patients underwent the ophthalmoscopy, fundus fluorescein angiography (FFA) and ultra-wide field OCTA examination. The 24 mm×20 mm scanning mode was chosen for OCTA. Based on the results of FFA, the detection rate of ultra-wide field OCTA on retinal non-perfusion areas in RVO eyes was calculated, and the detection performance was analyzed by the receiver operating characteristic (ROC) curve.
Results　In this study, 28 eyes (58.3%) were detected with non-perfusion areas using FFA, in which 27 eyes (96.4%) were detected by ultra-wide field OCTA. The non-perfusion area not detected by ultra-wide field OCTA was located beyond the inspection range of ultra-wide field OCTA. In the remaining 20 eyes, ultra-wide field OCTA detected the retinal non-perfusion area over the macula lutea in 1 eye. It was masked by low fluorescence caused by hemorrhage in FFA. ROC analysis showed that the sensitivity and specificity of ultra-wide field OCTA in detecting non-perfusion areas in eyes with RVO were 83.3%and 100%, respectively, and the area under curve was 0.957.
Conclusion　Ultra-wide field OCTA shows a high detection rate, high efficiency and good accuracy in the non-perfusion area in RVO eyes, and it can find the non-perfusion area missed by FFA.

参考文献/References:

［1］　SCHMIDT E U,GARCIA A J,GERENDAS B S,MIDENA E,SIVAPRASAD S,TADAYONI R,et al.Guidelines for the management of retinal vein occlusion by the european society of retina specialists ［J］.Ophthalmologica,2019,242(3):123-162.
［2］　SONG P,XU Y,ZHA M,ZHANG Y,RUDAN I.Global epidemiology of retinal vein occlusion:a systematic review and meta-analysis of prevalence,incidence,and risk factors［J］.J Glob Health,2019,9(1):010427.
［3］　JAULIM A,AHMED B,KHANAM T,CHATZIRALLI I P.Branch retinal vein occlusion:epidemiology,pathogenesis,risk factors,clinical features,diagnosis,and complications.An update of the literature［J］.Retina,2013,33(5):901-910.
［4］　CHAN C K,IP M S,VANVELDHUISEN P C,ODEN N L,SCOTT I U,TOLENTINO M J,et al.SCORE Study Investigator Group.SCORE Study report #11:incidences of neovascular events in eyes with retinal vein occlusion［J］.Ophthalmology,2011,118(7):1364-1372.
［5］　SPAIDE R F,KLANCNIK J M,JR COONEY M J.Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography［J］.JAMA Ophthalmol,2015,133(1):45-50.
［6］　SUZUKI N,HIRANO Y,YOSHIDA M,TOMIYASU T,UEMURA A,YASUKAWA T,et al.Microvascular abnormalities on optical coherence tomography angiography in macular edema associated with branch retinal vein occlusion［J］.Am J Ophthalmol,2016,161:126-132.e1.
［7］　LI J Q,TERHEYDEN J H,WELCHOWSKI T,SCHMID M,LETOW J,WOLPERS C,et al.Prevalence of retinal vein occlusion in europe:a systematic review and meta-analysis［J］.Ophthalmologica,2018,241(4):1-7.
［8］　KASHANI A H,CHEN C L,GAHM J K,ZHENG F,RICHTER G M,ROSENFELD P J,et al.Optical coherence tomography angiography:A comprehensive review of current methods and clinical applications［J］.Prog Retin Eye Res,2017,60:66-100.
［9］　RODRíGUEZ F J,STAURENGHI G,GALE R,Vision Academy Steering Committee.The role of OCT-A in retinal disease management［J］.Graefes Arch Clin Exp Ophthalmol,2018,256(11):2019-2026.
［10］　COSCAS F,GLACET B A,MIERE A,CAILLAUX V,UZZAN J,LUPIDI M,et al.Optical coherence tomography angiography in retinal vein occlusion:evaluation of superficial and deep capillary plexa［J］.Am J Ophthalmol,2016,161:160-171.
［11］　INOUE M,JUNG J J,BALARATNASINGAM C,DANSINGANI K K,DHRAMI G E,SUZUKI M,et al.A comparison between optical coherence tomography angiography and fluorescein angiography for the imaging of type 1 neovascularization［J］.Invest Ophthalmol Vis Sci,2016,57(9):314-323.
［12］　KHAYAT M,WILLIAMS M,LOIS N.Ischemic retinal vein occlusion:characterizing the more severe spectrum of retinal vein occlusion［J］.Surv Ophthalmol,2018,63(6):816-850.
［13］　NOBRE C J,KEANE P A,SIM D A,BRADLEY P,AGRAWAL R,ADDISON P K,et al.Systematic evaluation of optical coherence tomography angiography in retinal vein occlusion［J］.Am J Ophthalmol,2016,163:93-107.e6.
［14］　HAYREH S S,ZIMMERMAN M B,PODHAJSKY P.Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics［J］.Am J Ophthalmol,1994,117(4):429-441.
［15］　TSAI G,BANAEE T,CONTI F F,SINGH R P.Optical coherence tomography angiography in eyes with retinal vein occlusion［J］.J Ophthalmic Vis Res,2018,13(3):315-332.
［16］　KUEHLEWEIN L,AN L,DURBIN M K,SADDA S R.Imaging areas of retinal nonperfusion in ischemic branch retinal vein occlusion with swept-source OCT microangiography［J］.Ophthalmic Surg Lasers Imaging Retina,2015,46(2):249-252.
［17］　KIMURA M,NOZAKI M,YOSHIDA M,OGURA Y.Wide-field optical coherence tomography angiography using extended field imaging technique to evaluate the nonperfusion area in retinal vein occlusion［J］.Clin Ophthalmol,2016,10:1291-1295.
［18］　刘长颖,王杰,陈芳,赵旭峥,梁丽,韩亚楠.多方位光相干断层扫描血管成像对Ⅳ期糖尿病视网膜病变患眼视网膜及视盘新生血管的检出分析［J］.中华眼底病杂志,2020,36(5):349-353.
LIU C Y,WANG J,CHEN F,ZHAO X Z,LIANG L,HAN Y N.Detection of retinal and optic disc neovascularization in patients with stage 4 diabetic retinopathy by multidirectional optical coherence tomography angiography［J］.Chin J Ocul Fundus Dis,2020,36(5):349-353.

相似文献/References:

[1]王刚.曲安奈德联合氪激光治疗视网膜静脉阻塞的临床疗效观察[J].眼科新进展,2013,33(7):000.
[2]马宇 刘意 郭娟 周利晓.金纳多联合血栓通对视网膜静脉阻塞患者同型半胱氨酸水平的影响[J].眼科新进展,2013,33(9):000.
[3]袁子茗 王帅 宋蓓雯 胡健艳 吴强.维速达尔光动力疗法诱导兔视网膜静脉阻塞的实验研究[J].眼科新进展,2012,32(9):000.
[4]李娟娟 李燕.先天性及获得性视盘血管袢的临床观察[J].眼科新进展,2013,33(11):000.
[5]陆秉文 吴星伟.视网膜静脉阻塞黄斑水肿患者玻璃体内注射ranibi-zumab后视野变化[J].眼科新进展,2013,33(12):000.
[6]金昱,石安娜,刘淼. 玻璃体内注射雷珠单抗（Ranibizumab）治疗视网膜静脉阻塞继发黄斑水肿[J].眼科新进展,2014,34(9):855.[doi:10.13389/j.cnki.rao.2014.0236]
[7]周洁,王宏彬,王文亭.雷珠单抗治疗视网膜静脉阻塞的临床研究[J].眼科新进展,2016,36(1):070.[doi:10.13389/j.cnki.rao.2016.0020]
　ZHOU Jie,WANG Hong-Bin,WANG Wen-Ting.Efficacy of intravitreal injection of ranibizumab for retinal vein occlusion[J].Recent Advances in Ophthalmology,2016,36(1):070.[doi:10.13389/j.cnki.rao.2016.0020]
[8]袁牧之,林颖,刘泉.视网膜静脉阻塞患者血浆和泪液中血管内皮生长因子表达的研究[J].眼科新进展,2016,36(5):468.[doi:10.13389/j.cnki.rao.2016.0125]
　YUAN Mu-Zhi,LIN Ying,LIU Quan.Expression of VEGF in plasma and tears of patients with RVO[J].Recent Advances in Ophthalmology,2016,36(1):468.[doi:10.13389/j.cnki.rao.2016.0125]
[9]王琛,李东豪,闻毅颐.玻璃体内注射康柏西普联合周边视网膜选择性光凝治疗视网膜静脉阻塞继发黄斑水肿的疗效及安全性[J].眼科新进展,2016,36(5):471.[doi:10.13389/j.cnki.rao.2016.0126]
　WANG Chen,LI Dong-Hao,WEN Yi-Yi.Intravitreal injection of conbercept combined with selective peripheral retinal photocoagulation for macular edema secondary to retinal vein occlusion[J].Recent Advances in Ophthalmology,2016,36(1):471.[doi:10.13389/j.cnki.rao.2016.0126]
[10]董秀芬,钟华.Angio-OCT在眼科疾病临床应用中研究进展[J].眼科新进展,2016,36(7):697.[doi:10.13389/j.cnki.rao.2016.0185]
　DONG Xiu-Fen,ZHONG Hua.Application of Angio-OCT in ophthalmic diseases[J].Recent Advances in Ophthalmology,2016,36(1):697.[doi:10.13389/j.cnki.rao.2016.0185]
[11]夏洋,周吉林,黄永健,等.康柏西普联合激光光凝治疗视网膜分支静脉阻塞继发黄斑水肿患者远期视力恢复的影响因素研究[J].眼科新进展,2021,41(2):174.[doi:10.13389/j.cnki.rao.2021.0037]
　XIA Yang,ZHOU Jilin,HUANG Yongjian,et al.Prognostic factors for visual outcome after injection of Conbercept combined with laser photocoagulation for macular edema due to branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2021,41(1):174.[doi:10.13389/j.cnki.rao.2021.0037]

备注/Memo

备注/Memo:
四川省科技计划项目（编号：2022YFS0234，2021ZYD0108）；四川省干部保健科研课题（编号：川干研ZH2019-201）；四川省卫生健康委员会研究课题（编号：192D012）
更新日期/Last Update: 2023-01-05